Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
FSD Pharma (TSE:HUGE)
CNQX:HUGE
FSD Pharma (HUGE) Stock Price & Analysis
23 Followers
HUGE Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$0.68 - C$2.38
Previous CloseC$0.69
Volume71.13K
Average Volume (3M)36.51K
Market Cap
C$28.31M
Enterprise ValueC$23.47M
Total Cash (Recent Filing)$3.51M
Total Debt (Recent Filing)$339.20K
Price to Earnings (P/E)-1.1
Beta0.68
Next Earnings
May 10, 2024EPS EstimateN/A
Last Dividend Ex-Date
Nov 27, 2023Dividend YieldN/A
Share Statistics
EPS (TTM)-0.63
Shares Outstanding39,376,795
10 Day Avg. Volume31,243
30 Day Avg. Volume36,505
Standard Deviation0.20
R-Squared0.04
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)2.61
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-1.84
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
FSD Pharma News
PremiumCompany Announcements
FSD Pharma Delves into Weight Loss and Liver Health
PremiumCompany Announcements
FSD Pharma Increases Stake in Recovery Drink Innovator
PremiumCompany Announcements
FSD Pharma Faces Nasdaq Compliance Challenge
PremiumCompany Announcements
FSD Pharma Faces Nasdaq Compliance Challenge
PremiumCompany Announcements
FSD Pharma Reports Year-End Financials & R&D Progress
PremiumCompany Announcements
FSD Pharma Advances MS Treatment with New Study
HUGE FAQ
What was FSD Pharma’s price range in the past 12 months?
FSD Pharma lowest stock price was C$0.68 and its highest was C$2.38 in the past 12 months.
What is FSD Pharma’s market cap?
Currently, no data Available
When is FSD Pharma’s upcoming earnings report date?
FSD Pharma’s upcoming earnings report date is May 10, 2024 which is in 21 days.
How were FSD Pharma’s earnings last quarter?
FSD Pharma released its earnings results on Mar 28, 2024. The company reported -C$0.057 earnings per share for the quarter, beating the consensus estimate of -C$0.19 by C$0.133.
Is FSD Pharma overvalued?
According to Wall Street analysts FSD Pharma’s price is currently Overvalued.
Does FSD Pharma pay dividends?
FSD Pharma pays a Notavailable dividend of <C$0.01 which represents an annual dividend yield of N/A. See more information on FSD Pharma dividends here
What is FSD Pharma’s EPS estimate?
FSD Pharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does FSD Pharma have?
FSD Pharma has 40,437,595 shares outstanding.
What happened to FSD Pharma’s price movement after its last earnings report?
FSD Pharma reported an EPS of -C$0.057 in its last earnings report, beating expectations of -C$0.19. Following the earnings report the stock price went down -2.083%.
Which hedge fund is a major shareholder of FSD Pharma?
Currently, no hedge funds are holding shares in TSE:HUGE
---
FSD Pharma Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Crowd Wisdom
Negative
Last 7 Days ▼ 1.3%
Last 30 Days ▲ 0.3%
Last 30 Days ▲ 0.3%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-72.97%
12-Months-Change
Fundamentals
Return on Equity
-83.28%
Trailing 12-Months
Asset Growth
-54.51%
Trailing 12-Months
Company Description
FSD Pharma
FSD Pharma, Inc. is a specialty biotech pharmaceutical research and development company. It focuses on developing over time a robust pipeline of FDA-approved synthetic compounds targeting the endocannabinoid system of the human body to treat certain diseases of the central nervous system and autoimmune disorders of the skin, GI tract, and the musculoskeletal system. The company was founded by Thomas Fairfull, Zeeshan Saeed and Anthony J. Durkacz in 1994 and is headquartered in Cobourg, Canada.
---
Technical Analysis
---